PacBio and Nvidia Lead Stock Market Gains Amid Industry Developments

PacBio, a genomics company, saw its stock rise by 5.8% on Monday after it was announced that Sampled had secured a five-year contract worth up to $27.1 million from the U.S. Department of Veterans Affairs to support research using PacBio Revio sequencing systems.

Nvidia also made significant gains, increasing by 2.7%, after authorizing an additional $150 billion for its share buyback program, taking the total authorization to $235 billion.

Palo Alto Networks stock rose by 5.1% on Monday following a price target increase from BTIG to $425 from $404 and a reiterated Buy rating.